Captrust Financial Advisors Bio Xcel Therapeutics, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$15.0 - $22.83 $420 - $639	28 Added 164.71%	45 $1,000
Q4 2021 Feb 14, 2022	SELL	$20.12 - $35.09 $5,030 - $8,772	-250 Reduced 93.63%	17 $0
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $494 - $660	-17 Reduced 5.99%	267 $8,000
Q1 2021 May 17, 2021	SELL	$39.04 - $64.6 $109,936 - $181,913	-2,816 Reduced 90.84%	284 $12,000
Q3 2020 Nov 17, 2020	BUY	$37.44 - $64.63 $106,704 - $184,195	2,850 Added 1140.0%	3,100 $139,000
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $4,405 - $14,677	250 New	250 $13,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.81M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.